Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
Working Capital/Sales

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 1.381.591.551.531.83

What is the latest Working Capital/Sales ratio of MARKSANS PHARMA ?

The latest Working Capital/Sales ratio of MARKSANS PHARMA is 1.38 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20261.38
Mar20251.59
Mar20241.55
Mar20231.53
Mar20221.83

How is Working Capital/Sales of MARKSANS PHARMA Trending?

Years Working Capital/Sales % Change
Mar2026 1.38
-13.21
Mar2025 1.59
2.58
Mar2024 1.55
1.31
Mar2023 1.53
-16.39
Mar2022 1.83 -

Other Financial Ratios of MARKSANS PHARMA


Compare Working Capital/Sales ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹15,300.0 Cr 5.6% 6% 94.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,597.0 Cr 1% -3.3% 13.1% Stock Analytics
DIVIS LABORATORIES ₹255,195.0 Cr 2.6% 10.8% 57.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,712.0 Cr 2.7% 0.3% 39.6% Stock Analytics
CIPLA ₹113,423.0 Cr 2.4% -1.1% -12.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,195.0 Cr 2.5% 0.8% -8.5% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

5.6%

6%

94.8%

SENSEX

-1%

-4.9%

-11%


You may also like the below Video Courses